Shankar, Rohit http://orcid.org/0000-0002-1183-6933
Marston, Xiaocong Li http://orcid.org/0000-0002-0025-8197
Danielson, Vanessa http://orcid.org/0000-0001-5857-6254
Do Rego, Bronwyn http://orcid.org/0009-0000-1801-6228
Lasagne, Reginald http://orcid.org/0009-0003-9280-6342
Williams, Oliver http://orcid.org/0009-0006-7761-1389
Groves, Lara http://orcid.org/0000-0002-9577-1021
Funding for this research was provided by:
LivaNova
Article History
Received: 13 November 2023
Revised: 14 December 2023
Accepted: 19 December 2023
First Online: 19 January 2024
Declarations
:
: RS has received institutional and research support from LivaNova, UCB, Eisai, Veriton Pharma, Bial, Angelini, UnEEG and Jazz/GW pharma outside the submitted work. He holds grants from NIHR AI, SBRI and other funding bodies all outside this work. VD, BDR, RL, and OW were employees of LivaNova at the time of the study and manuscript submission. XLM and LG were employees of OPEN Health at the time of the study and manuscript submission, who received consulting fees from LivaNova.
: The study is a retrospective observational study. Only de-identified secondary data were used for the study. Approval of the study was obtained from the data governance framework for the Clinical Practice Research Datalink, underpinned by the Research Data Governance process (Protocol Reference ID: 22_002201).
: Not applicable for a retrospective observational study.